Coeptis Therapeutics Holdings, Inc. Annual Interest Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2021 to 2023.
  • Coeptis Therapeutics Holdings, Inc. Interest Expense for the quarter ending June 30, 2024 was $66.1K, a 54.9% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. Interest Expense for the twelve months ending June 30, 2024 was $300K, a 73.7% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $108K, a 50.7% decline from 2022.
  • Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $218K, a 16.7% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $108K -$111K -50.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-08-16
2022 $218K +$31.3K +16.7% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-08-16
2021 $187K Jan 1, 2021 Dec 31, 2021 10-K/A 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.